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ABSTRACT  1 
 2 
Background: Spontaneous deep intracerebral hemorrhage (ICH) is a devastating subtype of 3 
stroke without specific treatments. It has been thought that smooth muscle cell (SMC) 4 
degeneration at the site of arteriolar wall rupture may be sufficient to cause hemorrhage. 5 
However, deep ICHs are rare in some aggressive small vessel diseases that are characterized 6 
by significant arteriolar SMC degeneration.  Here we hypothesized that a second cellular 7 
defect may be required for the occurrence of ICH. 8 
Methods: We studied a genetic model of spontaneous deep ICH using Col4a1
+/G498V
 and 9 
Col4a1
+/G1064D
 mouse lines that are mutated for the alpha1 chain of Collagen type IV. We 10 
performed high resolution imaging and molecular analyses of cerebroretinal microvessels, 11 
genetic rescue experiments, vascular reactivity analysis and computational modeling. We also 12 
examined post-mortem brain tissues from patients with sporadic deep ICH.  13 
Results: We identified in the normal cerebroretinal vasculature a novel segment between 14 
arterioles and capillaries, herein called the transitional segment (TS), that is covered by mural 15 
cells distinct from SMCs and pericytes. In Col4a1 mutant mice, this TS was 16 
hypermuscularized, with a hyperplasia of mural cells expressing more contractile proteins, 17 
whereas the upstream arteriole exhibited a loss of SMCs. Mechanistically, TS showed a 18 
transient increase in proliferation of mural cells during post-natal maturation. Mutant brain 19 
microvessels, unlike mutant arteries, displayed a significant upregulation of SM genes and 20 
Notch3 target genes, and genetic reduction of Notch3 in Col4a1
+/G498V
 mice protected against 21 
ICH. Retina analysis showed that hypermuscularization of the TS was attenuated but 22 
arteriolar SMC loss unchanged in Col4a1
+/G498V
, Notch3
+/- 
mice. Moreover, 23 
hypermuscularization of the retinal TS increased its contractility and tone and raised the 24 
intravascular pressure in the upstream feeding arteriole. Consistently, we similarly found 25 
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hypermuscularization of the TS and focal arteriolar SMC loss in brain tissues from patients 1 
with sporadic deep ICH. 2 
Conclusions: Our results suggest that hypermuscularization of the TS, via increased Notch3 3 
activity, is involved in the occurrence of ICH in Col4a1 mutant mice, by raising the 4 
intravascular pressure in the upstream feeding arteriole and promoting its rupture at the site of 5 
SMC loss. Our human data indicate that these 2 mutually reinforcing vascular defects may 6 
represent a general mechanism of deep ICH. 7 
 8 
  9 
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Clinical Perspective 1 
What is new ?  2 
 Col4a1 mutant mice, a genetic model of spontaneous deep intracerebral hemorrhage 3 
(ICH), exhibit excessive muscularization of the transitional segment (TS) at the interface 4 
between arterioles and capillaries, as a result of increased Notch3 activity, in addition to 5 
focal loss of smooth muscle cells in arterioles, in the brain and the retina. 6 
 Genetic reduction of Notch3 in Col4a1 mutant mice protects against ICH. 7 
 Analysis of the retinal vasculature supports the concept of 2 mutually reinforcing vascular 8 
defects as a mechanism of deep ICH, in which hypermuscularization of TS raises the 9 
intravascular pressure in the upstream feeding arteriole crippled by smooth muscle cell 10 
loss, and this ultimately leads to arteriolar rupture. 11 
What are the clinical implications? 12 
 Spontaneous ICH accounts for 10-20% of all strokes and is the most devastating subtype 13 
of stroke, without specific treatments. 14 
 Because these 2 mutually reinforcing vascular defects are present in the brain of patients 15 
with sporadic deep ICH, this may represent a general mechanism of deep ICH and a 16 
putative therapeutic target. 17 
 18 
 19 
 20 
  21 
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INTRODUCTION 1 
Spontaneous (non-traumatic) intracerebral hemorrhage (ICH) accounts for 9-27% of all 2 
strokes
1
, causing about 3 million cases worldwide per year
2
. This stroke subtype is the most 3 
devastating one because it is associated with high mortality rates (55% at one year) and major 4 
permanent disabilities in patients who survive
3,4
. Cerebral small vessel diseases underlie the 5 
vast majority of ICHs
5
: so-called hypertension-related arteriopathy accounts for almost all 6 
deep ICH (occurring in the basal ganglia, thalamus, cerebellum or brainstem), whereas just 7 
over half of lobar ICH is associated with cerebral amyloid angiopathy. Importantly, as 8 
population blood pressure control has improved, epidemiological studies have found a 9 
decreasing prevalence of uncontrolled hypertension at the time of ICH diagnosis
6,7
, yet ICH 10 
incidence appears unchanged
3
.  11 
Pathological studies on postmortem human brains have suggested that deep ICH results from 12 
focal smooth muscle cell (SMC) degeneration in the media of cerebral arterioles and 13 
replacement with collagen, which is structurally stiff and brittle
8–10
. It has been speculated that 14 
the weakened arteriole dilates and eventually bursts at bifurcation sites and that this occurs 15 
preferentially in deep brain regions where penetrating arterioles are exposed to high perfusion 16 
pressure due to their proximity to the circle of Willis
11
. However, SMC loss alone may not be 17 
sufficient to cause ICH because deep ICHs are rare in some aggressive small vessel diseases 18 
that are characterized by significant arteriolar SMC degeneration
12
. Emerging evidence 19 
indicates that mural cells exhibit a variety of cell phenotypes along the microvascular tree
13
, 20 
raising the possibility that mural cells may respond in different ways to the factors underlying 21 
the arteriopathy.  22 
Animal models of spontaneous deep ICHs are very rare. Beside sporadic forms of deep ICH, 23 
monogenic forms largely indistinguishable from sporadic forms have been characterized 24 
offering excellent opportunities for mechanistic studies using genetic models. Heterozygous 25 
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mutations in the α1 (COL4A1) chain of collagen type IV, which is a major component of 1 
vascular basement membranes (BM), are associated with spontaneous deep ICHs in humans 2 
or mice in the absence of hypertension, although with incomplete penetrance 
14,15
.  3 
Herein, we hypothesized that a second cellular defect may be required for the occurrence of 4 
ICH and we used Col4a1 mutant mice to test this hypothesis. 5 
  6 
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METHODS 1 
The data that support the findings of this study are available from the corresponding author 2 
upon reasonable request.  3 
Human tissue samples 4 
Post-mortem frozen and paraffin embedded human brain samples were obtained from the UK 5 
Medical Research Council Brain Bank of the University of Edinburgh, with informed consent 6 
from patients or their families for their inclusion in the Lothian IntraCerebral Haemorrhage, 7 
Pathology, Imaging and Neurological Outcome (LINCHPIN) study
5
. The use of postmortem 8 
brain tissues for research was approved by the Institutional Review Board of INSERM 9 
(IRB00003888, n°17-392).  10 
Mice 11 
Col4a1
+/G498V
 mice used in this study were generated on a mixed 50% C57BL/6 – 50% 12 
129/Sv background as described previously
14,16
. Col4a1
+/G1064D
 mice on a C57BL/6 13 
background were obtained from GlaxoSmithKline (Brentford, UK). Notch3
+/-
 mice were 14 
described previously
17
  and maintained on a 129/Sv background. All animals were 15 
randomized for their genotype information and were included in the study. Mice were 16 
maintained in a specific pathogen-free environment. Experiments were conducted in 17 
accordance with the guidelines of our local institutional Animal Care and Use Committee 18 
(Lariboisiere-Villemin, CEA9). 19 
All other methods are described in the supplementary material. 20 
Statistical analysis 21 
Unless specified otherwise, data in figures and text are presented as means ± standard 22 
deviation. Statistical significance was determined using either two-tailed Student’s t-test, two-23 
tailed Mann-whitney test, one-way analysis of variance (ANOVA) followed by Tukey’s post 24 
hoc test, 2-way ANOVA followed by Bonferroni post hoc test or Kruskal-Wallis test followed 25 
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by Dunn’s post hoc test, as specified in figure legends (GraphPad Prism 7 software). For large 1 
samples (n>8), data were analyzed using parametric or non-parametric tests depending on the 2 
result of the D’Agostino-Pearson omnibus normality test. Chi-square test was used to 3 
compare the penetrance of ICHs between different groups. 4 
  5 
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RESULTS 1 
An unbiased, marker-based mural cell characterization of the retinal vasculature  2 
We focused on the superficial retinal vascular network that exhibits many similarities with the 3 
cerebral vasculature and offers the advantage of being nearly planar on flat-mounted retina 4 
preparations and highly stereotyped (Fig 1A). Moreover, we recently established the validity 5 
of the retinal vasculature as a study model in the COL4A1 disease
14
. Flat-mounted retinas of 6 
adult mice were stained for various mural cell markers including smooth muscle contractile 7 
proteins —α smooth muscle actin (α-SMA) or smooth muscle myosin heavy chain 8 
(SMMHC)—, the intermediate filament protein desmin, the plasma membrane chondroitin 9 
sulfate proteoglycan (NG2), Platelet-derived growth factor receptor-beta (PDGFR-, or 10 
aminopetidase N (CD13). Markers of endothelial cells (VE-cadherin), astrocytes (GFAP, 11 
aquaporin 4), BM (perlecan, COL4A2) or elastic lamina (elastin or Alexa Fluor 633–12 
conjugated hydrazide
18
) were also used. Arterioles (average diameter 26 µm) were surrounded 13 
by α-SMAhigh, SMMHChigh, desminlow, CD13low, NG2low and PDGFR-low SMCs. Here, 14 
SMCs had a flat ring-shape and were circumferentially organized in a perpendicular manner 15 
towards the vessel axis (Figs 1B, S1 and S2). Veins (average diameter 32 µm) were 16 
surrounded by stellate-shaped α-SMAlow, SMMHClow, desminhigh, CD13low, NG2low and 17 
PDGFR-high SMCs (Figs 1B, S1 and S2). Capillaries (average diameter 4.1 µm) were 18 
covered by α-SMAnegative, SMMHCnegative, desminhigh, CD13high, NG2high and PDGFR-high 19 
mural cells, hereafter called pericytes, showing a protruding ovoid cell body (“bump on a 20 
log”) embedded in the BM, and elongated thin processes (Figs 1B, S1 and S2). Interestingly 21 
the vascular segment located between arterioles and capillaries (average diameter 10 µm) was 22 
covered by distinct mural cells, expressing both arteriolar SMC and pericyte markers. Namely 23 
these cells were α-SMAhigh, SMMHChigh, desminhigh, CD13high, NG2high and PDGFR-high. 24 
These mural cells had a pericyte-like protruding cell body, which contained the nucleus and 25 
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where NG2 staining was mostly concentrated (Fig S2B), but larger and irregular ensheathing 1 
processes projecting orthogonally over the vessel, bright for α-SMA and SMMHC (Figs 1B, 2 
S1 and S2). Thereafter, this vascular segment will be referred as “the transitional segment” 3 
(TS) and its mural cells as “transitional cells”. TS were present at every arteriole/capillary 4 
transition, usually at the 1
st
-3
rd
 branch orders (0 being the proximal arteriole starting in the 5 
center of the retina) (Fig S3). Interestingly, TS, unlike arterioles, were devoid of elastic fibers 6 
(Fig. S4C-D). On the other hand, expression of VE-cadherin, perlecan, COL4A2, GFAP and 7 
aquaporin 4 was almost comparable along the arteriovenous bed (Fig. S4 and data not shown).  8 
Col4a1
+/G498V
 mice have hypermuscularized TS in addition to arteriolar SMC loss in the 9 
retinal vasculature  10 
Next, we studied microvascular changes in the retina of adult Col4a1
+/G498V 
mice (6-month-11 
old). Our previous work had shown segmental and focal loss and apoptosis of SMCs in the 12 
retinal arterioles, starting from 3 months of age
14
. In keeping with this finding, we observed 13 
that mural cell loss was strictly restricted to retinal arterioles and that remaining SMCs stained 14 
negative for NG2 and low for desmin, suggesting that mutant SMCs have not undergone a 15 
phenotypic switch towards a transitional cell or pericyte phenotype (Fig. S5). In striking 16 
contrast, mutant TS exhibited a significantly higher number of mural cells with an increased 17 
expression of contractile proteins including α-SMA or SMMHC (Fig. 2 A-C) that was already 18 
present at one month of age (Fig S6), and we coined the term “hypermuscularization” to 19 
designate these alterations. On the other hand, cell density and phenotype of pericytes were 20 
unchanged in mutant capillaries although pericyte coverage was slightly increased (Fig. S7) 21 
and no overt anomalies of SMCs were noticed in mutant veins.  22 
To delineate the underlying cellular mechanisms of TS pathology, we examined whether there 23 
was abnormal mural cell proliferation or apoptosis in mutant mice. The vascularization of the 24 
murine retina occurs after birth and prior works suggest that mural cells are derived from a 25 
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common NG2+ precursor cell already present at birth
19,20
. At post-natal day 10 (P10), 1 
arterioles were already easily recognizable as -SMA bright vessels, yet SMCs were still 2 
NG2 bright and had a protruding cell body, whereas TS just started to become discernable 3 
(Figs 2D and S8). At P10, TS consisted in small branches covered by rounded mural cells that 4 
were NG2 bright and -SMA low-to-very pale (white-boxed area in Fig. 2D). We found that 5 
the length and -SMA expression level of TS were comparable between wildtype and mutant 6 
mice (Fig. 2F). Incorporation of 5-ethynyl-2’-deoxyuridine (EdU) revealed a low number of 7 
proliferating mural cells in TS, but which was significantly higher in Col4a1
+/G498V
 mice (Fig. 8 
2D-F). Very few apoptotic mural cells were present in TS in wildtype and mutant mice (Fig 9 
S8D).  At P23, TS had further grown and almost reached the adult mature state described 10 
above. The length of TS was comparable between wildtype and mutant mice but -SMA 11 
expression level was significantly increased in mutant mice. Proliferating mural cells were no 12 
longer detected and almost no apoptotic mural cells were observed in Col4a1
+/+
 and 13 
Col4a1
+/G498V
 mice (Fig S8). SMC proliferation or apoptosis in arterioles was also very low at 14 
P10 and P23, and notably comparable between wildtype and mutant mice (Fig. S8).  15 
The brain vasculature of Col4a1
+/G498V
 and Col4a1
+/G1064D
 mutant mice display similar 16 
hypermuscularization of TS in addition to arteriolar SMC loss 17 
We next assessed whether the brain vasculature of Col4a1 mutant mice displayed similar 18 
changes to those of the retinal vasculature. Immunostaining of thick (100µm) brain slices 19 
indicated that brain arterioles, like retinal arterioles, were surrounded by α-SMAhigh , 20 
desmin
low
 and NG2
low 
SMCs, forming narrow circumferential bands, and brain TS were 21 
surrounded by α-SMAhigh , desminhigh and NG2high mural cells having larger and irregular 22 
ensheathing processes and a protruding cell body containing the nucleus wrapped by a bright 23 
NG2 staining  (Figs 3A-B and S9). Consistent with our previous work
14
, we detected in 24 
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Col4a1
+/G498V
 mice focal and segmental loss of SMCs in penetrating arterioles within regions 1 
prone to ICH, like the thalamus (data not shown). Importantly, we found that α-SMA 2 
expression in TS was significantly increased in Col4a1
+/G498V
 mice compared to Col4a1
+/+
 3 
mice, not only in the thalamus but also in other brain regions, such as the cortex and striatum, 4 
that are spared by ICH (Fig 3C-D).  5 
The combination of arteriolar SMC loss and hypermuscularization of TS was similarly 6 
observed in Col4a1
+/G1064D
 mice, another independent Col4a1 mutant line 
21–23
 in both the 7 
retina and the brain, although vascular pathology was more severe than in Col4a1
+/G498V
 mice 8 
(expanded results, Figs S10-S11).  9 
To understand the reason behind the differences between TS and arterioles in mutant mice, 10 
and because Col4a1 mutations have been shown to decrease COL4 expression
14
, we asked 11 
whether COL4 expression levels were different between mutant arterioles and TS. Brain 12 
cryosections (20µm-thick)  of Col4a1
+/+
 and Col4a1
+/G498V
 mice were immunostained with a 13 
monoclonal antibody specific for COL4A2, which assembles with COL4A1 to form the 14 
COL4A1A1A2 heterotrimer. Remarkably, COL4A2 immunoreactivity was significantly 15 
decreased in mutant TS but unchanged in mutant arterioles (Fig. S12).  16 
In the ensuing study, we focused on the role of the hypermuscularization of TS in ICH. 17 
 18 
Expression of SMC genes and Notch3 target genes is upregulated in Col4a1
+/G498V
 brain 19 
microvessel preparations enriched in TS  20 
To investigate molecular changes occurring in TS, we purified brain microvessels from 21 
Col4a1
+/+
 and Col4a1
+/G498V
 mice using sequential filtrations through nylon meshes of 22 
decreasing pore sizes. Immunostaining of brain vessels retained on the 100 µm-nylon mesh 23 
mainly comprised arterioles and veins (Fig 4A, top panel) whereas the 40 µm-retentate was 24 
 13  
 
 
enriched in TS, and also in capillaries (Fig 4A, bottom panel). We found that genes coding for 1 
the contractile proteins α-SMA and SMMHC were significantly upregulated in the TS 2 
enriched fraction of Col4a1
+/G498V
 mice, as well as genes coding for desmin, the actin-binding 3 
proteins calponin and SM22 and the transcription factor myocardin, suggesting an increased 4 
differentiation of mural cells (Fig 4B).  5 
The Notch3 receptor is predominantly expressed in vascular SMCs and Notch3 signaling 6 
pathway plays a pivotal role in the development and maturation of blood vessels
24
. Moreover, 7 
recent work suggests that activation of the Notch3 pathway promotes pulmonary arterial 8 
hypertension by stimulating SMC proliferation and muscularization of small pulmonary 9 
arteries
25
. Given these observations, and the finding that Notch3 is also expressed in 10 
transitional cells (Fig. S13), we suspected that hypermuscularization of the TS could be 11 
mediated by a dysregulation of the Notch3 pathway, and thus we quantified the expression of 12 
target genes regulated by Notch3
26,27
 (Supplementary table 1). Because our brain microvessel 13 
preparations also contained endothelial cells, we selected Notch3 target genes that were 14 
expressed exclusively in mural cells according to previous works
26,27
 or single cell RNAseq 15 
analysis of mouse brain microvessels 16 
(http://betsholtzlab.org/VascularSingleCells/database.html) 
13
. We found that 7 out of 11 of 17 
these Notch3 target genes were upregulated in brain microvessels of Col4a1
+/G498V 
mice (Fig. 18 
4C). In striking contrast, expression level of SM marker genes was essentially unchanged in 19 
dissected brain arteries of Col4a1
+/G498V 
mice and only 2 out of 11 of Notch3 target genes 20 
were upregulated in mutant brain arteries (Fig. 4D,E). Altogether, our results suggest that the 21 
increased muscularization of mutant TS arises from an increased activation of Notch3 22 
pathway. 23 
Genetic reduction of Notch3 in Col4a1
+/G498V
 mice attenuates the hypermuscularization of 24 
TS in the retina and protects against ICH 25 
 14  
 
 
To confirm that activation of the Notch3 pathway contributed to the hypermuscularization of 1 
TS and assess whether this hypermuscularization was involved in ICH in Col4a1 mutant 2 
mice, we adopted a genetic interaction approach. To avoid confounding effects induced by the 3 
complete loss of Notch3, which causes prominent loss of SMCs
17,28,29
, we generated and 4 
analyzed Col4a1
+/G498V
 lacking 1 allele of Notch3, along with their control littermates, at 6 5 
months of age. Loss of a single allele of Notch3 in wildtype mice (Notch3
+/-
) has no 6 
detectable morphological effect on the retinal microvasculature
29
 but significantly reduces 7 
Notch3 activity 
26
. Genetic reduction of Notch3 in Col4a1 mutant mice (Col4a1
+/G498V
, 8 
Notch3
+/-
) had no significant effect on SMC loss in retinal arterioles (Fig. 5A,B), however, it 9 
strikingly significantly attenuated α-SMA expression and mural cell number in TS (Fig 10 
5C,D). Remarkably, the mean number of ICH was significantly reduced in Col4a1
+/G498V
, 11 
Notch3
+/-
 mice compared to Col4a1
+/G498V
, Notch3
+/+
 mice (Fig 5E,F). Moreover, the 12 
penetrance of ICH was drastically reduced in Col4a1
+/G498V
, Notch3
+/-
 mice, with ICH being 13 
detected in only 20% of mice compared to near 60% in the Col4a1
+/G498V
, Notch3
+/+
 group 14 
(P=0.024 by the Chi-square test)..  15 
Mutant TS are more contractile in response to thromboxane receptor agonist and increased 16 
intraluminal pressure 17 
To pinpoint the mechanism by which hypermuscularization of the TS contributed to the 18 
occurrence of ICH, we next performed functional studies. To achieve this, we used the retina 19 
where TS can be easily identified ex vivo under phase contrast microscopy (Fig S3). To study 20 
vascular responses closest to physiological conditions, we developed an ex vivo pressurized 21 
retina preparation (Fig 6A). We assessed the response of TS to two standard vasoconstrictors, 22 
KCl and the thromboxane mimetic U-46619 on retina explants from Col4a1
+/+
 and 23 
Col4a1
+/G498V
 mice aged 6 months (Fig. 6B and supplementary Table 2). Addition of 60 mM 24 
KCl to the superfusion chamber elicited a robust and quick constriction of wildtype TS, with a 25 
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trend toward a stronger constriction in Col4a1
+/G498V
 vessels (Fig S14). U-46619 (10-100nM) 1 
produced a concentration-dependent constriction of TS that was significantly increased in 2 
Col4a1
+/G498V
 mice at 50 nM (36% diameter reduction in mutant mice versus 3% in control 3 
mice) (Fig 6C,D). We also examined the contractile response of TS to increased intraluminal 4 
pressure. Both Col4a1
+/+
 and Col4a1
+/G498V
 TS decreased luminal diameter in response to the 5 
pressure change, however Col4a1
+/G498V
 TS exhibited a ~5.5-fold greater constriction than 6 
Col4a1
+/+
 TS (Fig. 6E-F).  7 
Hypermuscularization of the TS cripples the pressure drop in the microvasculature 8 
We then hypothesized that the higher tone and contractility of mutant TS could compromise 9 
the pressure drop along the microvasculature. An abnormally higher intravascular pressure at 10 
the level of arterioles combined with SMC loss might favor their rupture. Measuring 11 
intravascular pressure in vivo in the microvasculature is extremely challenging and yet limited 12 
to larger vessels. Moreover, assessing the pressure drop along the microvascular bed would 13 
require several measurements at different locations which is not feasible in vivo. Therefore, 14 
we used computational modeling to simulate the pressure distribution in different parts of the 15 
microvasculature in the retina. We used an established mathematical model of an 16 
artery/arteriolar human retinal network in which mural cells are implemented as fibers in the 17 
vascular wall
30,31
 (Fig. 7A). In Col4a1 mutant mice, density of mural cells was decreased in 18 
arterioles to model SMC loss and increased in TS to simulate the hypermuscularization (Fig. 19 
7B). Measurements of systolic and diastolic blood pressures by tail-cuff plethysmography 20 
showed a 11% decrease in Col4a1 mutant mice (Fig. S15). Hence, blood pressures at the 21 
entry of the retinal vascular network were decreased proportionally in Col4a1 mutant mice 22 
and used as input parameters for the model (Fig. 7B). Intravascular pressure was then 23 
simulated in control and mutant mice all along the arterioles and TS (Fig. 7C). Fig 7D shows 24 
the values of systolic and diastolic intravascular pressures in 10 different locations during a 25 
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typical cardiac cycle. In control mice, pressure continuously dropped from 40 to 20 mmHg. In 1 
Col4a1 mutant mice, a lower pressure was observed in proximal arterioles (positions 1-3) due 2 
to the slight systemic hypotension. However, pressure drop was reduced resulting in higher 3 
intravascular pressure in middle-size arterioles (positions 4-8) and TS (positions 9-10) 4 
compared to controls. Moreover, in this part of the vascular network the pulse pressure 5 
(difference between the systolic and diastolic pressure) was larger in Col4a1 mutant mice. 6 
Thus, these data suggest that the hypermuscularization of TS leads to an abnormally elevated 7 
mean and pulse pressure in the feeding upstream arteriole. 8 
Diffuse mural cell loss is not associated with ICH  9 
Our findings above predict that, conversely, loss of transitional cells in TS in addition to SMC 10 
loss in arterioles should not lead to ICH (Fig. 7E). Consistent with previous reports
17,28,29
, 11 
cerebral and retinal arterioles of mice completely lacking Notch3 exhibited prominent SMC 12 
loss (Figs S16-S17). However, unlike Col4a1 mutant mice, we found that TS in Notch3
-/-
 13 
mice also showed dramatic loss of transitional cells in both the retina and the brain (Figs S16-14 
S17). Computational modeling revealed that arterioles in Notch3
-/-
 mice were exposed to 15 
lower intravascular pressure compared to controls (Fig. 7C,D). Remarkably, Perl’s staining 16 
revealed no ICH in Notch3
-/- 
mice aged 10-12 months (Fig. S17).  17 
Cerebral TS are hypermuscularized in humans with sporadic deep ICH 18 
Finally, we tested if hypermuscularization of TS was also present in humans with sporadic 19 
ICH. Similarly to murine cerebral vessels, human cerebral arteries were surrounded by flat 20 
ring-shaped SMCs whereas α-SMA positive smaller vessels (diameter between 5 and 15 µm) 21 
were covered by mural cells having a protruding ovoid cell body (Fig. S18). These vessels are 22 
most likely TS, although transitional cells could not be further characterized because none of 23 
the antibodies against NG2, desmin or aminopeptidase N worked on human post-mortem 24 
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brain tissue in our experimental conditions. To assess vascular remodeling in human deep 1 
ICH, we immunostained for α-SMA paraffin sections of postmortem brain tissues from adults 2 
who suffered from spontaneous deep ICH (Fig. 8A) and age and sex-matched control subjects 3 
(Supplementary table 3). To ensure that vascular lesions were not secondary to ICH, we used 4 
tissue sampled in the hemisphere contralateral to the hemorrhage, and we analyzed sections 5 
through the basal ganglia. In agreement to what has been previously reported
8
, we observed 6 
that some, but not all, arteries in patients had a markedly reduced α-SMA staining in the 7 
media with an uneven distribution of stained SMC, consistent with segmental and focal SMC 8 
degeneration (Fig. S19). In contrast, TS in ICH patients often showed a marked increased 9 
immunostaining for α-SMA compared to controls, suggesting an increased number or 10 
hypertrophy of mural cells (Fig 8B). We imaged cross-sectional profiles of 525 randomly 11 
selected TS/arterioles in patients and controls. Quantification of the ratio of the area stained 12 
for α-SMA (media) over the area of the lumen confirmed that α-SMA staining was 13 
significantly thicker in TS (lumen diameter between 5 and 15 µm) from ICH patients whereas 14 
α-SMA staining in arterioles (lumen diameter > 15µm) was comparable between ICH patients 15 
and controls (Fig. 8C-D). Overall, our data suggest that hypermuscularization of TS is a 16 
common pathological mechanism in spontaneous deep ICH.  17 
 18  
 
 
DISCUSSION  1 
 2 
In the present study, we investigated the microvascular pathology in mice mutant for 3 
collagen type IV, a model of hereditary spontaneous deep ICH, and provided strong 4 
experimental evidence for two mutually-reinforcing defects of the brain microvasculature as a 5 
new mechanism for ICH. In our previous study, we had demonstrated that ICH originate from 6 
deep brain arteries with focal and segmental loss of SMC
14
. In the present study, we 7 
demonstrate that TS, the downstream microvessels at the interface between arteries and 8 
capillaries, show an exaggerated muscularization with higher contractility and tone. Our data 9 
support a mechanism in which hypermuscularization of mutant TS is driven by increased 10 
Notch3 activity, cripples the pressure drop along the arterio-capillary axis, raising the 11 
intravascular pressure in the upstream feeding arteriole and promoting its rupture at the site of 12 
SMC loss (Fig. 7E). We found similar microvascular lesions in post mortem brain tissues 13 
from patients with sporadic deep ICH, indicating that this may represent a general mechanism 14 
of deep ICH.  15 
 16 
Zonation of microvascular pathology in Col4a1-related small vessel disease 17 
Several groups have highlighted the diversity of mural cells in the brain microvasculature 18 
as arterioles branch into capillaries based on cellular morphology, -SMA content or vascular 19 
territory
32,33
. Recently, Vanlandewijck, He and colleagues proposed the concept of mural cell 20 
zonation, by which these cells can be grouped in distinct populations according to their gene 21 
repertoire
13
. Herein, we took advantage of the flat mounted retina preparation, in which the 22 
arteriovenous axis can be observed in a single plane, to precisely define the phenotype of 23 
mural cells at the arteriole-capillary interface, by using a combination of several mural cell 24 
markers and high-resolution imaging. Consistent with recent reports
32,33
, we found that 25 
 19  
 
 
microvessels at the interface between arterioles and capillaries (mean diameter 10 µm), herein 1 
called TS, are covered by a population of mural cells that are distinct from the canonical ring-2 
shaped -SMA positive SMCs located in arterioles and arteries, and the canonical -SMA 3 
negative pericytes, which have a protruding cell body and extend thin and long processes 4 
along the capillaries. We further established that these mural cells robustly express markers of 5 
both canonical SMCs and pericytes and extend large and short processes but have a 6 
protruding cell body. We then demonstrated the presence of similar transitional cells in the 7 
cerebral vessels. We believe that the name of  transitional cell, rather than “contractile 8 
pericyte” 34,35,  “ensheathing pericyte”32 or “pre-capillary SMC”33 better reflects the similarity 9 
and the continuum between these mural cells and the adjacent canonical SMCs and pericytes.  10 
Remarkably, the zonation of mural cells, as described above, coincides with the zonation 11 
of microvascular pathology in Col4a1 mutant mice. Notably, our time course, cellular, 12 
molecular and genetic experiments strongly suggest that the exaggerated muscularization of 13 
the TS and arteriolar SMC loss are driven by different mechanisms.   14 
 15 
Mechanism of excessive muscularization of TS in Col4a1 mutant mice 16 
Increased -SMA expression and mural cell numbers in TS include several possible 17 
underlying mechanisms.  Analysis of the retinal vasculature at P10, the earliest time point 18 
when TS were discernable, revealed that proliferation of mural cells, although low, was 19 
transiently increased in mutant TS. While the increased number of transitional cells may 20 
largely contribute to the increased expression of SM contractile proteins, our finding of an 21 
upregulation of several SM genes including myocardin, a transcription factor critically 22 
involved in SMC differentiation, is consistent with an enhanced differentiation of transitional 23 
cells in mutant TS— noting that we did not find evidence of a premature differentiation of 24 
these cells. 25 
 20  
 
 
Our findings that Notch3 target genes were upregulated in mutant brain microvessels 1 
and that hypermuscularization of retinal TS in Col4a1
+/G498V 
mice was attenuated by genetic 2 
reduction of Notch3, suggest that increased Notch3 activity is a driver of TS pathology. This 3 
conclusion is consistent with a number of previous studies that clearly established a pivotal 4 
role of Notch3 on early mural cell specification, differentiation and expression of SMC 5 
genes
17,28,29,36–38
. It is also worth mentioning that Notch3 has been identified as a mediator of 6 
SMC proliferation and muscularization of small pulmonary arteries in the context of 7 
pulmonary hypertension
25
. Considering a recent report showing that  COL4 can repress 8 
Notch3 signaling
39
, it is plausible that the reduction in COL4 expression in mutant TS could 9 
be involved in this increased Notch3 activity. Nevertheless, further studies are warranted to 10 
better understand the mechanisms by which Col4a1 mutations increase Notch3 activity in 11 
mutant TS and of Notch3-mediated hypermuscularization of mutant TS. In this regard, it will 12 
be critical to better understand the molecular and physiological factors that underlie the 13 
differentiation of mural cells in transitional or arteriolar vessels. However, one current 14 
limitation is the absence of specific marker or genetically encoded reporter of transitional 15 
cells.  16 
 17 
Why TS respond to Col4a1 mutations with hypermuscularization whereas arteries do 18 
not?  19 
We found that arteries differed from TS in several respects. Notably, Col4a1 mutation did not 20 
affect expression of COL4 and marginally affected expression of Notch3 target genes in 21 
mutant arteries. This different response of arterial SMCs and transitional cells to Col4a1 22 
mutation may originate from their distinct intrinsic molecular identity highlighted in this 23 
study. Furthermore, the distinct environment of SMCs in arterioles compared to mural cells in 24 
transitional segments offers an additional possible explanation. Indeed, communication 25 
 21  
 
 
between endothelial cells and SMCs in arteries is hampered by the presence of an internal 1 
elastic lamina which restricts cell-cell communication to myoendothelial projections 
40
. In 2 
contrast, endothelial cells are in direct contact with transitional cells in TS, which are devoid 3 
of elastic lamina.  Thus, the distinct pathology of arteriolar SMCs and transitional cells in 4 
Col4a1 mutant mice may arise from cell autonomous effects versus endothelial cell-mediated, 5 
i.e. non-cell autonomous, effects respectively
41
. Future work is needed to investigate this 6 
hypothesis.  7 
 8 
Two mutually-reinforcing defects of the brain microvasculature as a key mechanism for 9 
spontaneous deep ICH 10 
We recently reported  that Col4a1 mutant mice exhibited arteriolar SMC loss in the brain 11 
and the retina, and that ICH originated from arterioles with severe loss of SMC
14
. In this 12 
study, we demonstrated that mutant TS in the brain and the retina were hypermuscularized.  13 
Our Notch3 genetic reduction experiment in Col4a1 mutant mice further suggests that 14 
hypermuscularization of the TS plays a role in the occurrence of ICH. By analyzing the retina, 15 
which is a tractable central nervous system preparation where vessels of the superficial layer 16 
are at similar depths and can be easily fully imaged, we demonstrated that 17 
hypermuscularization of TS was attenuated and arteriolar SMC loss unchanged in Col4a1 18 
mutant mice haploinsufficient for Notch3. Remarkably, these mice were protected against 19 
hemorrhage. Additional studies would be desirable to confirm that hypermuscularization of 20 
TS is similarly attenuated and arteriolar SMC loss similarly unchanged in the brain of Col4a1 21 
compound heterozygotes, although such quantifications are still extremely challenging 22 
because the cerebral vasculature spans several spatial scales and forms a highly complex 23 
network. Moreover, our demonstration in Notch3 null mice that a severe loss of mural cells in 24 
both arterioles and TS does not necessarily lead to ICHs, lends further support to the concept 25 
 22  
 
 
that the hypermuscularization of TS in addition to arteriolar SMC loss is involved in ICH 1 
occurrence.  2 
Hypermuscularization of TS is predicted to locally decrease vessel diameter, increase 3 
vascular resistance and raise the intravascular pressure in the upstream proximate arteriole, 4 
hence favoring its rupture at the site of SMC loss. Both our experimental data and our 5 
computational modeling support these predictions. First, using our pressurized retina 6 
preparation, we found that pressure increase caused a significantly higher reduction in the 7 
diameter of TS in Col4a1 mutant mice compared to control mice. Second, our computational 8 
modeling revealed that the pressure drop along the arterio-TS axis was crippled in Col4a1 9 
mutant mice, ie with an abnormally higher intravascular pressure in the proximate feeding 10 
arteriole, despite the fact that Col4a1 mutant mice were slightly hypotensive. Notably, our 11 
computational modeling approach showed that arterioles in Notch3 null mice were instead 12 
exposed to lower intravascular pressure, which likely protected them against rupture and 13 
hemorrhage as observed experimentally.  14 
ICHs in Col4a1 mutant mice preferentially occur in the deep parts of the brain. This 15 
anatomical specificity of ICH is likely attributed in part to the following factors. First, in a 16 
previous study, we reported that arteriolar SMC loss predominated in the deep penetrating 17 
arteries
14
. Secondly, although hypermuscularization of TS is not restricted to ICH prone 18 
regions, the mechanism by which it favors arteriolar rupture, namely by raising the 19 
intravascular pressure at the site of SMC loss, suggests that it could contribute to the regional 20 
specificity of ICH. Indeed, recent computational modeling in human suggests that 21 
intravascular pressure at the level of perforating arteries in the deep parts of the brain is higher 22 
than the one at the level of penetrating arteries in the cortex, owing to their anatomical 23 
proximity to the circle of Willis
42
. Therefore, it is anticipated that it is in those deep 24 
 23  
 
 
penetrating arteries that hypermuscularization of TS should produce the highest local 1 
elevation of intravascular pressure.  2 
 3 
Excessive muscularization of the TS in sporadic deep ICH   4 
In patients with sporadic deep ICH, SMC degeneration has been documented at the 5 
presumed site of arterial wall rupture for many years
10,11
. So far, the assumption has been 6 
made that vessel wall degeneration was uniquely responsible for bleeding.  Our findings in 7 
Col4a1 mutant mice, a genetic model of spontaneous deep ICH, prompted us to test the 8 
possibility that sporadic deep ICH in humans may also arise from a similar zonation of 9 
microvascular pathology. Remarkably, analysis of human post-mortem brain tissues from 10 
patients with spontaneous deep ICH revealed, in addition to segmental SMC degeneration in 11 
arteries, a thickening of -SMA staining in smaller vessels, consistent with a hyperplasia or 12 
hypertrophy of mural cells. Although, we could not unequivocally identify these vessels as TS 13 
because most of the mural cell markers used in the mouse did not work on human tissues in 14 
our experimental conditions, the presence of protruding cell nuclei and the internal diameter 15 
of the affected vessels, comprised between 5-15 µm, strongly suggest that these are TS. 16 
Hence our data suggest that the mechanism of ICH identified in Col4a1 mutant mice also 17 
operates in human sporadic deep ICH. Yet, whether Notch3 activity is similarly increased in 18 
TS in patients needs to be further investigated.  19 
Our findings open new opportunities towards the development of preventive therapies 20 
for ICH. Although several studies have established the benefit of blood pressure lowering in 21 
preventing the recurrence of ICH (secondary prevention) 
43–45
, our data suggest that 22 
pharmacological compounds targeting hypermuscularization of the TS may be more effective 23 
for both primary and secondary prevention of ICH. Notably, hypermuscularization of the TS 24 
may prove to be more easily druggable than arteriolar SMC loss.  25 
 24  
 
 
Conclusion 1 
Collectively our work is consistent with the new concept of two mutually-reinforcing 2 
defects of the brain microvasculature, with arteriolar SMC loss and exaggerated 3 
muscularization of the TS, as a new mechanism underlying hereditary and sporadic deep ICH. 4 
Hypermuscularization of this segment may represent a novel therapeutic target for ICH 5 
prevention. 6 
  7 
 25  
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FIGURES and LEGENDS 1 
 2 
 33  
 
 
Figure 1. Heterogeneity of mural cells in retinal vessels. Confocal pictures of adult mouse 1 
retina immunostained for α-SMA, NG2 and perlecan. A. Whole flat mounted retina (left 2 
panel). Higher magnification of the boxed region (right panel).  B. Higher magnification 3 
pictures of the boxed regions numbered in A, showing SMCs in arterioles (1), transitional 4 
cells in transitional segments (2), pericytes in capillaries (3) and SMCs in veins (4). 5 
Arrowheads show protruding cell body in transitional segments and capillaries. Scale bars: 1 6 
mm (A, left), 50 µm (A, right) and 5 µm (B). 7 
 8 
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 1 
 2 
Figure 2. TS in Col4a1
+/G498V
 retina are hypermuscularized in adult mice and exhibit 3 
increased mural cell proliferation during the post-natal maturation of the retinal 4 
vasculature. A. Representative confocal pictures of retinal TS from Col4a1
+/+
 and 5 
 35  
 
 
Col4a1
+/G498V
 mice aged 6 months stained for α-SMA, NG2 and perlecan. TS in mutant mice 1 
exhibit greater α-SMA fluorescence intensity and an increased number of transitional cells 2 
(arrowheads). B. Quantification of mural cell density and α-SMA mean fluorescence intensity 3 
in retinal TS of Col4a1
+/+
 and Col4a1
+/G498V 
mice at 6 months (n=7 mice per group). *** 4 
P=0.0001 **** P<0.0001 by Student’s t-test. C. Representative confocal pictures of TS of 5 
Col4a1
+/+
 and Col4a1
+/G498V 
mice at 6 months stained for SMMHC and perlecan showing 6 
higher SMMHC expression in mutant vessels. D. Representative confocal images of retinal 7 
arterioles (A) and TS (white boxes) of Col4a1
+/+
 and Col4a1
+/G498V 
mice aged 10 days, 8 
stained for EdU incorporation (4 hours) together with α-SMA, NG2, and DAPI— Shown are 9 
oversaturated images of α-SMA staining to better visualize TS (bottom panel). Yellow arrows 10 
depict proliferating mural cells in TS. Note the sustained cell proliferation in wildtype and 11 
mutant veins (V). E. Higher magnification views of the boxed area in D showing a 12 
proliferating mural cell in the TS of a Col4a1
+/G498V 
mouse (yellow arrow) F. Quantification 13 
of the total length of TS (P=0.8746) stained by α-SMA, mural cell proliferation in TS  (* 14 
P=0.0298) and α-SMA mean fluorescence intensity in TS (P=0.5753). Data were analyzed by 15 
Student’s t-test (n=4 mice per group). Scale bars: 20 µm (A, C), 50 µm (D) and 10 µm (E).   16 
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 1 
Figure 3. TS are present in the brain vasculature and are hypermuscularized in 2 
Col4a1
+/G498V
 mice. A, B Representative confocal pictures of an adult wildtype mouse brain 3 
immunostained for α-SMA, desmin, perlecan and Dapi. A. Low magnification view of a 4 
vascular tree. B. Higher magnification pictures of the boxed regions numbered in A, showing 5 
SMCs in arterioles (1), and transitional cells in TS (2). Arrowheads point to the protruding 6 
cell body of transitional cells in the TS, containing the nucleus. C. Representative confocal 7 
pictures of TS in the thalamus from Col4a1
+/+
 and Col4a1
+/G498V
 mice aged 6 months stained 8 
for α-SMA and desmin, showing increased -SMA immunoreactivity in mutant TS. 9 
Arrowheads point to cell nucleus of transitional cells. D. Quantification of α-SMA mean 10 
fluorescence intensity in TS of Col4a1
+/+
 and Col4a1
+/G498V
 mice aged 6 months in the 11 
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thalamus (*** P=0.0008), cortex (** P=0.005) and striatum (* P=0.0422). Data were 1 
analyzed by Student’s t-test (n=5 mice per group). Scale bars: 50 µm (A) and 10 µm (B,C). 2 
 3 
 4 
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 1 
Figure 4. Gene expression level of SMC genes and Notch3 target genes in brain 2 
microvessels and brain arteries of Col4a1
+/+
 and Col4a1
+/G498V
 mice. A. Microvessels were 3 
prepared from mouse brain by homogeneization and centrifugation into Ficoll solution as 4 
described in the supplementary method section. Vessel preparations were then fractionated 5 
successively through 100 and 40 µm nylon meshes. Pictures show vessels retained on each 6 
nylon mesh (100 and 40 µm-fractions) stained for α-SMA, desmin, perlecan and DAPI. 7 
Arterioles (bright for α-SMA and low for desmin) were retained in the 100 µm-fraction and 8 
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40 µm-fractions were enriched in TS (bright for α-SMA and desmin) and capillaries. B, C. 1 
Relative mRNA levels of smooth muscle genes (B) and Notch3 target genes (C) measured by 2 
quantitative RT-PCR on 40 µm-fractions prepared from Col4a1
+/+
 and Col4a1
+/G498V
 adult 3 
mice (n=6 mice per group). Data are reported as a fold change over control mice and analyzed 4 
by Student’s t-test. α-SMA (*** P=0.0007), SMMHC (*** P=0.0002), Desmin (** 5 
P=0.0018), SM22 (**** P<0.0001), Calponin (** P=0.0041), Myocardin (** P=0.0013), 6 
PECAM (P=0.4934), Cdh6 (* P=0.0117), Grip2 (** P=0.0048), HeyL (** P=0.0035), Kcna5 7 
(** P=0.0060), Notch3 (P=0.9697), Nrip2 (*** P=0.0002), Pln (*** P=0.0007), S1pr3 8 
(P=0.0530), Susd5 (*** P=0.001), Tbx2 (P=0.1972), and Xirp1 (** P=0.0085). D, E. 9 
Relative mRNA levels of smooth muscle genes (D) and Notch3 target genes (E) measured by 10 
quantitative RT-PCR in dissected brain arteries from Col4a1
+/+
 and Col4a1
+/G498V
 adult mice 11 
(n=10 mice per group). Data are reported as a fold change over control mice and analyzed by 12 
Student’s t-test. α-SMA (P=0.7811), SMMHC (P=0.0506), Desmin (P=0.1680), SM22 13 
(P=0.9903), Calponin (P=0.8291), Myocardin (* P=0.0407), Cdh6 (P=0.0609), Grip2 14 
(P=0.5982), HeyL (P=0.1397), Kcna5 (P=0.8060), Notch3 (P=0.9669), Nrip2 (P=0.1677), 15 
Pln (** P=0.0062), S1pr3 (P=0.4643), Susd5 (P=0.4996), Tbx2 (* P=0.0309), and Xirp1 16 
(P=0.2664). Scale bar: 50 µm (A).  17 
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 1 
Figure 5. Genetic reduction of Notch3 attenuates the hypermuscularization of TS in the 2 
retina and protects Col4a1 mutant mice against ICH. Col4a1
+/G498V 
mice were crossed 3 
 41  
 
 
with Notch3
+/- 
mice and issued mice of the four following genotypes were screened for 1 
microvascular lesions and ICHs at 6 months of age: Col4a1
+/+
, Notch3
+/+
; Col4a1
+/+
 , 2 
Notch3
+/-
; Col4a1
+/G498V
, Notch3
+/+
 and Col4a1
+/G498V
, Notch3
+/-
. A. Representative confocal 3 
pictures of retinal arterioles stained for α-SMA and perlecan, showing SMC loss 4 
(arrowheads). B. Quantification of SMC loss in retinal arterioles showing no significant 5 
difference between Col4a1
+/G498V
, Notch3
+/+ 
and Col4a1
+/G498V
, Notch3
+/-
 mice (from left to 6 
right n=21, 16, 16 and 20 mice). Data were analyzed with Kruskal-Wallis and Dunn’s post-7 
hoc test. *** P=0.0005 **** P < 0.0001. C. Representative confocal pictures of retinal TS 8 
stained for α-SMA, NG2 and perlecan. Arrowheads show cell bodies of transitional cells. D. 9 
Quantification of mural cell density (from left to right n=10, 13,10 and 12 mice) and α-SMA 10 
mean fluorescence intensity (from left to right n=21, 16,16 and 20 mice) in TS showing a 11 
significant reduction in mural cell density and α-SMA intensity in Col4a1+/G498V Notch3+/- 12 
mice compared to Col4a1
+/G498V
 Notch3
+/+ 
mice. Data were analyzed by one-way ANOVA 13 
and Tukey’s post-hoc test. Mural cell density *** P=0.0004 ,**** P<0.0001. α-SMA 14 
intensity **** P<0.0001. E. Representative images of sagittal brain sections stained for 15 
hemosiderin. Arrowheads depict deep ICHs. F. Quantification of the number of ICH showing 16 
a significant decrease in ICH number in Col4a1
+/G498V
, Notch3
+/-
 mice compared to 17 
Col4a1
+/G498V
, Notch3
+/+ 
mice (from left to right n=21, 16,16 and 20 mice). Data were 18 
analyzed by Kruskal-Wallis and Dunn’s post-hoc test. * P=0.020, **** P<0.0001. Scale bars: 19 
20 µm (A, C) and 1 mm (E). 20 
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 1 
Figure 6. Agonist and pressure-induced contractile responses are greater in TS of 2 
Col4a1
+/G498V
 mice. A. Experimental setup to analyze contractility and tone of the TS in retina 3 
explants. The retina was dissected with the ophthalmic artery and pinned on a silicon platform 4 
with the vessels facing upwards and immerged in a perfusion chamber filled with circulating 5 
aCSF at 37°C. To pressurize retinal vessels, ophthalmic artery was cannulated on a 6 
micropipette fed with a gravity column of CSF at 40 mmHg. Changes in vessel diameters 7 
were observed using a water immersion 40X objective. B. Whole retina (left panel).  8 
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Schematic depicting TS (yellow, arrowheads) and arterioles (purple) analyzed in these 1 
experiments (right panel)— noting that the capillaries are not depicted in this schematic. C. 2 
Differential interference contrast images of TS from Col4a1
+/+
 and Col4a1
+/G498V
 mice aged 6 3 
months before (T0) and after addition of 50 nM thromboxane agonist U-46619 to the 4 
perfusion chamber. Bottom pictures show higher magnification view of boxed regions. 5 
Dashed white lines delineate the vessel wall. D. Dose response curve showing increased 6 
constriction of Col4a1
+/G498V 
TS in response to U-46619 (n=5 Col4a1
+/+ 
and 9 Col4a1
+/G498V
 7 
mice). E. Decreasing diameters of individual TS following 40 mmHg to 80 mmHg pressure 8 
increase at the ophthalmic artery F. Increased pressure-induced constriction in Col4a1
+/G498V
 9 
TS, shown as percent constriction (relative to 40 mmHg diameter, n=7 vessels from 3 10 
Col4a1
+/+ 
mice and n=14 vessels from 5 Col4a1
+/G498V
 mice). Data were analyzed by repeated 11 
measure 2-way ANOVA and Bonferroni’s multiple comparison test (panel D, ** P=0.0051), 12 
or Student’s t-test (panel F, ** P=0.0021). Scale bars: 1mm (B, left), 50 µm (B, right), 20 µm 13 
(C, top) and 5 µm (C, bottom). 14 
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Figure 7. Computational modeling predicts that excessive muscularization of the TS 1 
increases intravascular pressure in the upstream arteriolar segment. A. Geometry of the 2 
human retinal vascular tree used for mathematical modeling. Arterioles are depicted in grey 3 
and transitional segments in red. B. Input parameters used for mathematical modeling. C. 4 
Color-coded representation of systolic intravascular pressures along the retinal vascular tree 5 
simulated with the model in wild-type (top), Col4a1 mutant (middle) and Notch3
-/-
 (bottom) 6 
mice, showing that pressure is elevated in terminal arterioles and TS of Col4a1 mutant mice 7 
(arrowheads) but reduced in Notch3
-/-
 mice. D. Graph showing simulated systolic and 8 
diastolic pressures at 10 different points on the vascular tree represented in A. E. Proposed 9 
working model of the mechanism of arteriolar wall rupture in Col4a1 mutant mice. 10 
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 1 
Figure 8. Hypermuscularization of the TS in humans with deep ICH. A. Representative 2 
image of a CT-scan showing a deep ICH in the left thalamus. Brain tissue was sampled after 3 
death in the contralateral basal ganglia for immuno-histochemistry (boxed region) and 4 
embedded in paraffin. B. Representative images of cerebral TS (basal ganglia) stained for α-5 
SMA showing an hypermuscularization in ICH patients. Arrowheads point to transitional cell 6 
bodies. C. Schematic of the methodology used to quantify vessel wall remodeling. Cross-7 
sectional profiles of 525 randomly selected arterioles/TS were analyzed in each group.  D. 8 
Ratio of the vessel area stained for α-SMA (media) over the area of the lumen in cerebral 9 
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arterioles/TS from control and ICH patients. Vessels were stratified into two categories 1 
according to their lumen diameter (5 to 15 µm, TS and > 15 µm, arterioles). From left to right 2 
n = 368 and 382 TS (5-15µm), 106 and 128 arterioles (>15µm) analyzed. Data are presented 3 
as scatter plots with median value and first/third quartiles. Data were analyzed by Kruskal-4 
Wallis and Dunn’s post-hoc test. * P=0.016 Scale bar: 10 µm (B). 5 
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